IDEAYA BIOSCIENCES INC's ticker is IDYA and the CUSIP is 45166A102. A total of 98 filers reported holding IDEAYA BIOSCIENCES INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,319,578 | +10.1% | 85,974 | -4.1% | 0.00% | – |
| Q2 2023 | $2,106,446 | -12.6% | 89,636 | -48.9% | 0.00% | – |
| Q1 2023 | $2,410,246 | -22.0% | 175,546 | +3.2% | 0.00% | – |
| Q4 2022 | $3,091,371 | +84.8% | 170,136 | +51.7% | 0.00% | – |
| Q3 2022 | $1,673,000 | +123.4% | 112,138 | +106.6% | 0.00% | – |
| Q2 2022 | $749,000 | -59.6% | 54,282 | -67.2% | 0.00% | – |
| Q1 2022 | $1,853,000 | -29.1% | 165,586 | +49.8% | 0.00% | – |
| Q4 2021 | $2,614,000 | +2115.3% | 110,563 | +2298.9% | 0.00% | – |
| Q3 2021 | $118,000 | -31.0% | 4,609 | -43.6% | 0.00% | – |
| Q2 2021 | $171,000 | -21.2% | 8,179 | -11.6% | 0.00% | – |
| Q1 2021 | $217,000 | +119.2% | 9,248 | +31.2% | 0.00% | – |
| Q4 2020 | $99,000 | +2.1% | 7,050 | -8.9% | 0.00% | – |
| Q3 2020 | $97,000 | -24.8% | 7,741 | -14.9% | 0.00% | – |
| Q2 2020 | $129,000 | +892.3% | 9,100 | +193.9% | 0.00% | – |
| Q1 2020 | $13,000 | – | 3,096 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Canaan Partners X LLC | 2,660,713 | $29,774,000 | 30.23% |
| Logos Global Management LP | 2,850,000 | $31,892,000 | 4.14% |
| 5AM Venture Management, LLC | 1,398,066 | $15,644,000 | 3.42% |
| ACT CAPITAL MANAGEMENT, LLC | 173,500 | $1,941,000 | 2.05% |
| DAFNA Capital Management LLC | 490,061 | $5,484,000 | 1.43% |
| Boxer Capital, LLC | 2,202,812 | $24,649,000 | 1.27% |
| BVF INC/IL | 1,600,559 | $17,910,000 | 0.72% |
| Avidity Partners Management LP | 2,690,000 | $30,101,000 | 0.63% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 62,929 | $704,000 | 0.43% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 109,000 | $1,623,000 | 0.37% |